A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anyang Cancer Hospital
Anyang, China
Recruiting - the First Affiliated Hospital of Bengbu Medical University
Bengbu, China
Recruiting - Hunan Cancer Hospital
Changsha, China
Recruiting - Sichuan Cancer Hospital
Chengdu, China
Recruiting - Dongguan People'S Hospital
Dongwan, China
Recruiting - Fujian Cancer Hospital
Fuzhou, China
Recruiting - Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, China
Recruiting - the First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou, China
Recruiting - the First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Recruiting - the Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
Recruiting - Harbin Medical University Cancer Hospital
Ha’erbin, China
Recruiting - Shandong Cancer Hospital
Jinan, China
Recruiting - Jiangxi Cancer Hospital
Nanchang, China
Recruiting - Guangxi Medical University Affiliated Cancer Hospital
Nanning, China
Recruiting - Shanghai East Hospital
Shanghai, China
Recruiting - Shanghai Ninth People'S Hospital
Shanghai, China
Recruiting - Liaoning Cancer Hospital
Shenyang, China
Recruiting - Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
Shenzhen, China
Recruiting - Shanxi Cancer Hospital
Taiyuan, China
Recruiting - Tianjin Cancer Hospital
Tianjin, China
Recruiting - Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Recruiting - Henan Cancer Hospital
Zhengzhou, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Jan 2024
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 5 May 2026
- Registered enrollment
- 68
- Registry id
- NCT06214143
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.